The FDA will expedite the review of nicotine pouches from Philip Morris International (NYSE:PM), Altria (NYSE:MO), Reynolds American, a part of British American Tobacco (NYSE:BTI), and Turning Point ...

The process is based on the continuum of risk. As detailed by the agency, its case-by-case review of individual applications will increase efficiency by focusing review on the most critical elements ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Signage is seen outside of FDA headquarters in White Oak, Maryland (This Sept. 8 story has been corrected to add the ...

(Reuters) - The U.S. Food and Drug Administration plans to fast-track reviews of four tobacco firms' nicotine pouches in a pilot program launching on Monday, amid pressure from the Trump ...

Americans who smoke may soon be hearing a lot more about Zyn, the flavored nicotine pouches that have generated billions in ...

Flavored nicotine pouches called Zyn could soon be legally advertised as a lower-risk option for adults who smoke, as federal ...

Americans who smoke may soon be hearing a lot more about Zyn. That's the flavored nicotine pouch that's generated billions in ...

Videos from “Zynfluencers” have racked up tens of millions of views on social media platforms in recent years.

A NEW toxicological review published by the US National Library of Medicine (NLM) raises concerns that current discussions on ...